FIELD: chemistry; biochemistry.
SUBSTANCE: invention concerns biotechnology and health care. Recombinant adenovirus p53 is capable of lowering side effects of the type caused by anti-tumour chemotherapy and radio-therapy. In cancer patients, recombinant adenovirus p53 can restore operation of organs, including blood analysis, liver functioning, kidney functioning etc in order to improve the quality of life of patients, for example improvement of appetite, mental status and the like.
EFFECT: invention can be used in medicine.
19 cl, 7 dwg, 4 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT VIRUS MADE WITH VIRAL VECTOR AND HUMAN TUMOUR GENE SUPRESSOR, ITS APPLICATION | 2004 |
|
RU2392319C2 |
ADENOVIRUS-RECOMBINANT CARRYING ADENOVIRAL VECTOR STRUCTURE (VARIANTS), METHOD FOR RECOVERY FUNCTION OF PROTEIN P53 IN TUMOR CELL WITH DEFICIENCY OF NATURAL P53, METHOD FOR PRODUCING ADENOVIRUS-RECOMBINANT | 1994 |
|
RU2222600C2 |
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS | 2009 |
|
RU2520823C2 |
DESIGNING OF CARCINOLYTIC ADENOVIRUS RECOMBINANT, SPECIFICALLY EXPRESSING IMMUNOMODULATORY FACTOR GM-CSF IN TUMORAL CELLS AND ITS APPLICATION | 2004 |
|
RU2361611C2 |
APPLICATION OF ANTICANCER TRANSCRIPT MODIFYING AGENTS AND CHEMOTHERAPY OR RADIOTHERAPY | 2005 |
|
RU2389484C2 |
METHOD OF OBTAINING SYSTEM OF DIRECTED DELIVERY OF PROTEIN MOLECULES (ONCOLYTIC PROTEINS) INTO TUMOUR CELLS BASED ON ACTIVATED LYMPHOCYTES | 2013 |
|
RU2552609C1 |
RECOMBINANT ADENOVIRUS CONTAINING TRANS-SPLICING MEDIATING RIBOZYME, AND ANTI-CANCER THERAPEUTIC GENE, AND USING IT | 2012 |
|
RU2575620C2 |
MULTI-PURPOSE PROMOTER, EXPRESSION VECTOR, AND METHOD OF SELECTIVE KILLING CANCER CELLS WITH THEIR USE | 2012 |
|
RU2476596C1 |
METHOD OF INDUCING APOPTOSIS OF MALIGNANT TUMOUR CELLS OF COLORECTAL CANCER AND MEANS FOR ITS REALISATION | 2013 |
|
RU2551238C9 |
RECOMBINANT VARIOLOVACCINE VIRUS STRAIN VV-NS1-dGF PRODUCING NS1 PARVOVIRUS H-1 PROTEIN AND HAVING ONCOLYTIC ACTIVITY ON HUMAN GLIOBLASTOMA | 2018 |
|
RU2692628C1 |
Authors
Dates
2011-01-27—Published
2005-01-26—Filed